Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Deep Track Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 43
Average round size
info
The average size of a deal this fund participated in
$105M
Portfolio companies 35
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.09
Exits 17
Key employees Soon
Stages of investment
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Deep Track Capital:
Typical Co-investors
Deep Track Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Deep Track Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accelerated Technologies Partners New York, New York, United States
Aquiline Technology Growth New York, New York, United States
CareerOne Australia, New South Wales, Sydney
Foley Ventures Milwaukee, United States, Wisconsin
Guotai Venture Capital China, Jiangsu, Nantong
Insight Technology Capital Partners -
ITUARI Teknokent -
La Nevera Roja.com Community of Madrid, Madrid, Spain
Leonardo Venture Baden-Wurttemberg, Germany, Mannheim
LITTLEROCK Düsseldorf, Germany, Nordrhein-Westfalen
Rongxi Venture China, Jinshan District
South Suez Capital Grand Baie, Mauritius, Riviere du Rempart
Stingray Canada, Montréal, Quebec
Tab The Momentum Seoul, Seoul-t'ukpyolsi, South Korea
Techweek Chicago, Illinois, United States
Uber Alumni Syndicate -
Xalisco Ventures Pennsylvania, Pittsburgh, United States
Xinjiang Yuesheng Guquan Touzi Youxian Gongsi China, Ürümqi, Xinjiang
Zongheng Tianxia China, Guangdong, Shenzhen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Tubulis

Biotechnology
Health Care
Life Science
Pharmaceutical
Therapeutics
$151M14 Mar 2024 Munich, Bavaria, Germany

Mariana Oncology

Bioinformatics
Biometrics
Biopharma
Biotechnology
$175M07 Sep 2023 -

OnKure

Biotechnology
Life Science
Therapeutics
$54M23 May 2023 Boulder, Colorado, United States

TORL BioTherapeutics

Biopharma
Biotechnology
Clinical Trials
$158M13 Apr 2023 Los Angeles, California, United States

Hemab

Biotechnology
Life Science
Pharmaceutical
$135M21 Feb 2023 Copenhagen, Capital Region of Denmark, Denmark

Tourmaline Bio

Biotechnology
Clinical Trials
Therapeutics
$112M01 Jan 2023 New York, New York, United States

Apogee Therapeutics

Biotechnology
Life Science
Medical
Therapeutics
$149M07 Dec 2022 San Francisco, California, United States

Lusaris Therapeutics

Biotechnology
Therapeutics
$60M02 Nov 2022 Boston, Massachusetts, United States

Structure Therapeutics

Biopharma
Biotechnology
Genetics
Health Care
Medical
$33M03 Aug 2022 Shanghai, Shanghai, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Deep Track Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 43
Average round size 105M
Peak activity year 2023
Lead investments 2
Follow on index 0.09
Exits 17
Group Appearance index 0.98

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Tubulis

Biotechnology
Health Care
Life Science
Pharmaceutical
Therapeutics
$151M14 Mar 2024 Munich, Bavaria, Germany

Mariana Oncology

Bioinformatics
Biometrics
Biopharma
Biotechnology
$175M07 Sep 2023 -

OnKure

Biotechnology
Life Science
Therapeutics
$54M23 May 2023 Boulder, Colorado, United States

TORL BioTherapeutics

Biopharma
Biotechnology
Clinical Trials
$158M13 Apr 2023 Los Angeles, California, United States

Hemab

Biotechnology
Life Science
Pharmaceutical
$135M21 Feb 2023 Copenhagen, Capital Region of Denmark, Denmark

Tourmaline Bio

Biotechnology
Clinical Trials
Therapeutics
$112M01 Jan 2023 New York, New York, United States

Apogee Therapeutics

Biotechnology
Life Science
Medical
Therapeutics
$149M07 Dec 2022 San Francisco, California, United States

Lusaris Therapeutics

Biotechnology
Therapeutics
$60M02 Nov 2022 Boston, Massachusetts, United States

Structure Therapeutics

Biopharma
Biotechnology
Genetics
Health Care
Medical
$33M03 Aug 2022 Shanghai, Shanghai, China
Crunchbase icon

Content report

The following text will be sent to our editors: